Patent application number | Description | Published |
20090096034 | Partially and Fully Silicided Gate Stacks - Metal-oxide semiconductor (MOS) devices and techniques for the fabrication thereof are provided. In one aspect, a metal-oxide semiconductor device is provided comprising a substrate; and at least one n-channel field effect transistor (NFET) having a gate stack over the substrate. The NFET gate stack comprises an NFET gate stack metal gate layer; a first NFET gate stack silicon layer over the NFET gate stack metal gate layer; a second NFET gate stack silicon layer over a side of the first NFET gate stack silicon layer opposite the NFET gate stack metal gate layer, wherein an interface is defined between the first NFET gate stack silicon layer and the second NFET gate stack silicon layer; and an NFET gate stack silicide region that extends through the interface between the first NFET gate stack silicon layer and the second NFET gate stack silicon layer. | 04-16-2009 |
20090108352 | Metal-Gated MOSFET Devices Having Scaled Gate Stack Thickness - Metal-oxide semiconductor field effect transistor (MOSFET) devices having metal gate stacks and techniques for improving performance thereof are provided. In one aspect, a metal-oxide semiconductor device is provided comprising a substrate having a buried oxide layer at least a portion of which is configured to serve as a primary background oxygen getterer of the device; and a gate stack separated from the substrate by an interfacial oxide layer. The gate stack comprises a high-K layer over the interfacial oxide layer; and a metal gate layer over the high-K layer. | 04-30-2009 |
20090155969 | PROTECTION OF SIGE DURING ETCH AND CLEAN OPERATIONS - A method of making a semiconductor device includes forming a transistor structure having one of an embedded epitaxial stressed material in a source and drain region and a stressed channel and well, subjecting the transistor structure to plasma oxidation, and removing spacer material from the transistor structure. | 06-18-2009 |
20100009524 | METHOD FOR IMPROVING SEMICONDUCTOR SURFACES - A semiconductor fabrication method. The method includes providing a semiconductor substrate, wherein the semiconductor substrate includes a semiconductor material. Next, a top portion of the semiconductor substrate is removed. Next, a first semiconductor layer is epitaxially grown on the semiconductor substrate, wherein a first atom percent of the semiconductor material in the first semiconductor layer is equal to a certain atom percent of the semiconductor material in the semiconductor substrate. | 01-14-2010 |
20100140707 | Metal-Gated MOSFET Devices Having Scaled Gate Stack Thickness - Metal-oxide semiconductor field effect transistor (MOSFET) devices having metal gate stacks and techniques for improving performance thereof are provided. In one aspect, a metal-oxide semiconductor device is provided comprising a substrate having a buried oxide layer at least a portion of which is configured to serve as a primary background oxygen getterer of the device; and a gate stack separated from the substrate by an interfacial oxide layer. The gate stack comprises a high-K layer over the interfacial oxide layer; and a metal gate layer over the high-K layer. | 06-10-2010 |
20100224940 | Partially and Fully Silicided Gate Stacks - Metal-oxide semiconductor (MOS) devices and techniques for the fabrication thereof are provided. In one aspect, a metal-oxide semiconductor device is provided comprising a substrate; and at least one n-channel field effect transistor (NFET) having a gate stack over the substrate. The NFET gate stack comprises an NFET gate stack metal gate layer; a first NFET gate stack silicon layer over the NFET gate stack metal gate layer; a second NFET gate stack silicon layer over a side of the first NFET gate stack silicon layer opposite the NFET gate stack metal gate layer, wherein an interface is defined between the first NFET gate stack silicon layer and the second NFET gate stack silicon layer; and an NFET gate stack silicide region that extends through the interface between the first NFET gate stack silicon layer and the second NFET gate stack silicon layer. | 09-09-2010 |
Patent application number | Description | Published |
20080239341 | SYSTEM AND METHOD FOR CONTROLLING CONSISTENT COLOR QUALITY - A system and method control a consistent color quality of overlay colors and single separations of color. The method determines a first error for a first separation of a first color, wherein the first error has a first sign. The method identifies a second error for a second separation of a second color, wherein the second color is a different color than the first color, wherein the second error is based on an actual density value for toner particles printed transferred from the second separation, wherein the second error has a second sign. The method compares the first sign of the first error and the second sign of the second error. The method converges the actual density value of the second separation to a target position when the first sign is a different sign than the second sign. | 10-02-2008 |
20100091305 | SYSTEM AND METHOD FOR PRINTING TARGET COLORS WITH PROCESS COLORS UTILIZING PARALLEL FEEDFORWARD NEURAL NETWORKS - A system and method for printing target colors includes a print-engine interface and a neural network component. The print-engine interface is in operative communication with a print engine of a printing system. The neural network component is calibrated to the print engine for printing a target color on a substrate. The neural network is in operative communication with the print-engine interface and communicates a parameter associated with printing the target color on the substrate utilizing the print engine. | 04-15-2010 |
20120026517 | SYSTEM AND METHOD FOR GRADUALLY ADJUSTING A LOOK-UP TABLE FOR A PRINT ENGINE IN ORDER TO IMPROVE THE REGULATION OF COLOR QUALITY OF PRINTED IMAGES - Disclosed is a system and method for gradually adjusting a look-up table (LUT) for a print engine in order to improve the regulation of color quality of printed images. The LUT is updated so that a target value for a particular color is achieved. This corrects for a measured or predicted change in a tone reproduction curve. Depending upon the severity of the required adjustment, a series of incremental adjustments rather than a single adjustment can be made to the LUT table over a period of time. Each adjustment in the series can be limited to a predetermined maximum delta so that any corrections made to the LUT following the generation and evaluation of one test image and before the generation and evaluation of the next test image for the same target color are gradually and imperceptibly implemented (i.e., unnoticeable). | 02-02-2012 |
20130233191 | Tandem Printing System Having A Web Transport Controller With A Derived Drum Diameter - A tandem printing system for imaging a continuous web of material includes a first printer serially coupled to a second printer wherein the speed of the web can be adjusted to maintain image quality and to compensate for a change in a diameter of a driver drum. The change in the diameter of the driver drum can be derived from characteristics of the printing system including the amount of sag of the continuous web of material moving between the first printer and the second printer. | 09-12-2013 |
20140002531 | System And Method For Process Direction Alignment Of First And Second Side Printed Images | 01-02-2014 |
20140085368 | System and Method for First and Second Side Process Registration in a Single Print Zone Duplex Web Printer - A method of printhead registration in a duplex printer enables process direction registration of a first group of printheads and a second group of printheads in a single print zone that print first and second sides of a print medium concurrently. The first group of printheads is registered to a first reference printhead based on the process direction locations of a first plurality of marks printed by the first group of printheads at a first time between printed images on the first side of the print medium. The second group of printheads is registered to a second reference printhead based on the process direction locations of a second plurality of marks printed by the second group of printheads at a second time between printed images on the second side of the print medium. | 03-27-2014 |
20150331358 | SYSTEMS AND METHODS FOR IMPLEMENTING ADVANCED TONER DISPENSING AND EMPTYING OF TONER CARTRIDGE COMPONENTS IN IMAGE FORMING DEVICES - A system and method are provided for operating an image forming device in a first processor-controlled toner control operating mode to maintain a substantially constant dispense rate of toner material from a toner source or bottle. The disclosed systems and methods improve toner material dispensing from the toner source or bottle in the image forming device by transitioning to a second processor-controlled toner control operating mode as an amount of toner material in the toner source or bottle is determined to be in a depleted, or nearly-exhausted, state. The disclosed systems and methods compensate for a determined decrease in a toner dispense rate occurring as an amount of toner material remaining in the toner source or bottle is nearly depleted. One or more toner control parameters, including a pixel count gain, are modified in the second processor-controlled toner control operating mode. | 11-19-2015 |
Patent application number | Description | Published |
20100048489 | Stable Solid Formulation of A GC-C Receptor Agonist Polypeptide Suitable for Oral Administration - Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr (“linaclotide”) or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug. | 02-25-2010 |
20100286260 | MILNACIPRAN FORMULATIONS - The present invention provides formulations comprising milnacipran or pharmaceutically acceptable salts thereof (e.g., milnacipran hydrochloride), including immediate release formulations and modified formulations, such as delayed release and extended release formulations. The present invention provides formulations with improved stability and high bioavailability. Processes for preparing the formulations as well as methods of treating conditions by administering the formulations are also described. | 11-11-2010 |
20110059903 | Formulations Comprising Linaclotide - The present invention relates to stable compositions comprising linaclotide, as well as to various methods and processes for the preparation and use of the compositions. | 03-10-2011 |
20120213846 | Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration - Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr (“linaclotide”) or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug. | 08-23-2012 |
20130012454 | Orally Disintegrating Compositions of Linaclotide - The present invention relates to orally disintegrating or dissolving pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well to various methods and processes for the preparation and use of the compositions. | 01-10-2013 |
20130273169 | Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration - Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr (“linaclotide”; SEQ ID NO:1) or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug. | 10-17-2013 |
20140005128 | TREATMENTS OF GASTROINTESTINAL DISORDERS | 01-02-2014 |
20140023710 | MILNACIPRAN FORMULATIONS - The present invention provides formulations comprising milnacipran or pharmaceutically acceptable salts thereof (e.g., milnacipran hydrochloride), including immediate release formulations and modified formulations, such as delayed release and extended release formulations. The present invention provides formulations with improved stability and high bioavailability. Processes for preparing the formulations as well as methods of treating conditions by administering the formulations are also described. | 01-23-2014 |
20140287034 | Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration - Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr (“linaclotide”; SEQ ID NO:1) or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug. | 09-25-2014 |
20140378393 | Stable Formulations of Linaclotide - The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions. | 12-25-2014 |
20150031632 | Orally Disintegrating Compositions of Linaclotide - The present invention relates to orally disintegrating or dissolving pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions. | 01-29-2015 |
20150132375 | Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration - Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr (“linaclotide”; SEQ ID NO:1) or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug. | 05-14-2015 |